Abstract:A series of triazacyclononane and pendant arm triazacyclononane derivatives of iron() and ruthenium() have been investigated. The objective of this work was (i) to stabilise reactive Fe() dichloride fragments using N-monofunctionalised 1,4,7-triazacyclononane macrocycles and (ii) to investigate the effect of pendant group macrocycles in order to create different Ru() environments.
DALTON
“…The fourth RuÐN bond, Ru1ÐN12 in this particular structure, is 2.120 (3) A Ê . This is in contrast with the ®rst reported structure of this type, in which the pyridyl RuÐN bond of the pendant arm ligand is shorter than the RuÐN bonds involving the macrocycle (Gott et al, 2002). As expected, the longest RuÐN bond (Ru1ÐN4) lies trans to the carbonyl ligand.…”
Section: Commentcontrasting
confidence: 91%
“…The angle between the N atom of the macrocyclic ring and the N atom of the pendant pyridine arm donor [N1ÐRu1ÐN12 = 79.20 (12) ] is slightly smaller due to the more strained nature of the interaction of the pendant arm with the ruthenium centre. The three RuÐN bond distances [Ru1ÐN1 = 2.136 (3) A Ê , Ru1ÐN4 = 2.167 (3) A Ê and Ru1ÐN7 = 2.113 (3) A Ê ] are in agreement with expected values for general complexes of this type (Gott et al, 2002(Gott et al, , 2003; however, in the quoted reference, the values are more similar than in this instance. The fourth RuÐN bond, Ru1ÐN12 in this particular structure, is 2.120 (3) A Ê .…”
Section: Commentsupporting
confidence: 86%
“…We have recently published the ®rst studies of N-monofunctionalized 1,4,7-triazacyclononane complexes of ruthenium (Gott et al, 2002(Gott et al, , 2003. We have also investigated the reaction of such ligands with compounds of the general type RuHClL 4 (Gott & McGowan, 2003).…”
“…The fourth RuÐN bond, Ru1ÐN12 in this particular structure, is 2.120 (3) A Ê . This is in contrast with the ®rst reported structure of this type, in which the pyridyl RuÐN bond of the pendant arm ligand is shorter than the RuÐN bonds involving the macrocycle (Gott et al, 2002). As expected, the longest RuÐN bond (Ru1ÐN4) lies trans to the carbonyl ligand.…”
Section: Commentcontrasting
confidence: 91%
“…The angle between the N atom of the macrocyclic ring and the N atom of the pendant pyridine arm donor [N1ÐRu1ÐN12 = 79.20 (12) ] is slightly smaller due to the more strained nature of the interaction of the pendant arm with the ruthenium centre. The three RuÐN bond distances [Ru1ÐN1 = 2.136 (3) A Ê , Ru1ÐN4 = 2.167 (3) A Ê and Ru1ÐN7 = 2.113 (3) A Ê ] are in agreement with expected values for general complexes of this type (Gott et al, 2002(Gott et al, , 2003; however, in the quoted reference, the values are more similar than in this instance. The fourth RuÐN bond, Ru1ÐN12 in this particular structure, is 2.120 (3) A Ê .…”
Section: Commentsupporting
confidence: 86%
“…We have recently published the ®rst studies of N-monofunctionalized 1,4,7-triazacyclononane complexes of ruthenium (Gott et al, 2002(Gott et al, , 2003. We have also investigated the reaction of such ligands with compounds of the general type RuHClL 4 (Gott & McGowan, 2003).…”
“…The importance of (I) is shown in the wide use of the parent macrocycle, 1,4,7-triazacyclononane, and derived ligands in both coordination chemistry (Chaudhuri & Wieghardt, 1987) and organometallic chemistry (e.g. Male et al, 2000;Bambirra et al, 2001;Gott et al, 2002;Cui et al, 2003). Part of the widespread synthetic utility of (I) is the ability to introduce, by selective detosylation, further functional groups at one, two, or all three N atoms, thus giving a wide and varied range of multidentate ligands (Wainwright, 1997).…”
The X‐ray crystal structure of the title compound, C27H33N3O6S3, a key intermediate in the synthesis of 1,4,7‐triazacyclononane and its functionalized derivatives, is presented. Two of the p‐tosyl groups are coplanar with the macrocyclic ring, with the third pointing away from it.
“…In order to further investigate the effect of the size of the macrocycle ring of such hexadentate ligands on the coordination properties and ligand field, several Fe(II) systems that are based on triazamacrocycle units involving pyridylmethyl, aniline, methylimidazol, methylpyrazol or methylthiophene groups have been reported [50][51][52][53][54][55][56][57][58][59]. However, to the best of our knowledge, only two systems have been described as SCO systems in the solid state [50,51].…”
The unsymmetrical ligand 1-(2-aminophenyl)-4,7-bis(pyridin-2-ylmethyl)-1,4,7-triazacyclononane (L6) has been prepared and characterized by NMR spectroscopy. The L6 ligand is based on the triazamacrocycle (tacn) ring that is functionalized by two flexible 2-pyridylmethyl and one rigid 2-aminophenyl groups. Reaction of this ligand with Fe(ClO4)2·xH2O led to the complex [Fe(L6)](ClO4)2 (1), which was characterized as the first Fe(II) complex based on the unsymmetrical N-functionalized tacn ligand. The crystal structure revealed a discrete monomeric [FeL6]2+ entity in which the unsymmetrical N-functionalized triazacyclononane molecule (L6) acts as hexadentate ligand. As observed in the few parent examples that are based on the symmetrical N-functionalized tacn ligands, the triazacyclononane ring is facially coordinated and the N-donor atoms of the three functional groups (two pyridine and one aniline groups) are disposed in the same side of the tacn ring, leading to a distorted FeN6 environment. The magnetic studies of 1 revealed the presence of an incomplete spin crossover (SCO) transition above 425 K, whose progress would be prevented by a very exothermic thermal decomposition at ca. 472 K, as shown by thermogravimetric and DSC measurements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.